Literature DB >> 6750405

Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.

R A Fromtling, H J Shadomy, E S Jacobson.   

Abstract

Six acapsular strains of Cryptococcus neoformans obtained by chemical mutagenesis failed to produce a capsule in vivo and were avirulent in mice following high dose intramuscular, intraperitoneal or intravenous inoculation. Peritoneal granulomas were observed in all animals inoculated with the acapsular mutants. These granulomas were characterized by a large central mass consisting of intact, degenerating and necrotic yeast cells. This was surrounded by concentric layers of a broad band of histiocytes, a narrow band of fibroblasts, and around the periphery, a mass of lymphocytes and plasma cells. These isolates did not revert to an encapsulated or virulent state after more than a year of subculturing or 18 passages through mice.

Entities:  

Mesh:

Year:  1982        PMID: 6750405     DOI: 10.1007/bf00636177

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  15 in total

1.  Cryptococcosis histologically resembling histoplasmosis. A light and electron microscopical study.

Authors:  F Gutierrez; Y S Fu; H Lurie
Journal:  Arch Pathol       Date:  1975-07

2.  Effect of degree of encapsulation upon virulence of Cryptococcus neoformans.

Authors:  M L LITTMAN; E TSUBURA
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

3.  Auxotrophic mutants of Cryptococcus neoformans.

Authors:  E S Jacobson; D J Ayers
Journal:  J Bacteriol       Date:  1979-07       Impact factor: 3.490

4.  Histopathological observations in experimental cryptococcosis caused by a hypha-producing strain of Cryptococcus neoformans (Coward strain) in mice.

Authors:  H J Shadomy; H I Lurie
Journal:  Sabouraudia       Date:  1971-03

5.  Morphological variations of a hypha-forming strain of Cryptococcus neoformans (Coward strain) in tissues of mice.

Authors:  H I Lurie; H J Shadomy
Journal:  Sabouraudia       Date:  1971-03

6.  An evaluation of various environmental factors affecting the propagation of Cryptococcus neoformas.

Authors:  C M Ishaq; G S Bulmer; F G Felton
Journal:  Mycopathol Mycol Appl       Date:  1968-07-12

7.  Cryptococcus neoformans. 3. Inhibition of phagocytosis.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

8.  Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.

Authors:  R A Fromtling; R Blackstock; N K Hall; G S Bulmer
Journal:  Mycopathologia       Date:  1979-09-28       Impact factor: 2.574

9.  Cryptococcus neoformans IV. The Not-So-Encapsulated Yeast.

Authors:  F Farhi; G S Bulmer; J R Tacker
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

10.  Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.

Authors:  T R Kozel; J Cazin
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

View more
  92 in total

1.  Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans.

Authors:  Y C Chang; K J Kwon-Chung
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

2.  Capsular Material of Cryptococcus neoformans: Virulence and Much More.

Authors:  A Vecchiarelli; C Monari
Journal:  Mycopathologia       Date:  2012-02-08       Impact factor: 2.574

3.  Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.

Authors:  A Vecchiarelli; C Retini; C Monari; C Tascini; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.

Authors:  N Mozaffarian; J W Berman; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

5.  Eighty Years of Mycopathologia: A Retrospective Analysis of Progress Made in Understanding Human and Animal Fungal Pathogens.

Authors:  Vishnu Chaturvedi; Jean-Philippe Bouchara; Ferry Hagen; Ana Alastruey-Izquierdo; Hamid Badali; Anamelia Lorenzetti Bocca; Jose F Cano-Lira; Cunwei Cao; Sudha Chaturvedi; Sanjay H Chotirmall; Anne D van Diepeningen; Jean-Pierre Gangneux; Jesus Guinea; Sybren de Hoog; Macit Ilkit; Rui Kano; Weida Liu; Nilce M Martinez-Rossi; Marcia de Souza Carvalho Melhem; Mario Augusto Ono; Yuping Ran; Stephane Ranque; Celia Maria de Almeida Soares; Takashi Sugita; Philip A Thomas; Anna Vecchiarelli; Nancy L Wengenack; Patrick C Y Woo; Jianping Xu; Rosely M Zancope-Oliveira
Journal:  Mycopathologia       Date:  2018-11-30       Impact factor: 2.574

6.  Laccase expression in murine pulmonary Cryptococcus neoformans infection.

Authors:  Javier Garcia-Rivera; Stephanie C Tucker; Marta Feldmesser; Peter R Williamson; Arturo Casadevall
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  Macrolides Inhibit Capsule Formation of Highly Virulent Cryptococcus gattii and Promote Innate Immune Susceptibility.

Authors:  Shigeki Nakamura; Yurika Ikeda-Dantsuji; Lianjin Jin; Yoshitsugu Higashi; Masahiro Abe; Tatsuya Inukai; Minoru Nagi; Makoto Urai; Yoshitsugu Miyazaki
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 8.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

9.  Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule.

Authors:  A S Ibrahim; S G Filler; M S Alcouloumre; T R Kozel; J E Edwards; M A Ghannoum
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Cryptococcus neoformans: in vivo protection of mice by pretreatment with pyran copolymer.

Authors:  R A Fromtling; H J Shadomy; A M Kaplan
Journal:  Mycopathologia       Date:  1984-03-15       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.